eli lilly & co (LLY:Euronext Paris)
Transactions by ELI LILLY & CO (LLY) in the last 6 months
Ignyta, Inc. (NasdaqCM:RXDX) announced a private placement of 1,500,000 unregistered common shares at $20 per share with existing investor, Eli Lilly and Company for gross proceeds of $30,000,000 on November 6, 2015. The company has signed an agreement with the investor. The company will issue securities pursuant to exemption provided under Regulation D. The investor, without the company’s prior written consent, offer, pledge, sell, contract to sell, sell any option ...
Eli Lilly and Company (NYSE:LLY) acquired Locemia Solutions, LP from Windham Venture Partners, Robert Oringer, Walt Winshall and others October 9, 2015. Raymond Gietz of Weil Gotshal & Manges acted as legal advisor for Eli Lilly.
Immunocore Limited announced that it has received £205 million in its series A round of funding led by new investor, Malin Corporation plc on July 16, 2015. The oversubscribed transaction included participation from other new investors, Woodford Investment Management LLP, Eli Lilly and Company and RTW Investments, LLC and other new and existing investors. Malin Corporation plc invested £51,170,200 ($80,000,000) in the transaction. As part of the transaction, Adrian Howd, ...
Malin Corporation plc
RTW Investments, LLC
Woodford Investment Management LLP
|Abbott Laboratories||$45.42 USD||+0.01|
|AbbVie Inc||$60.00 USD||-0.29|
|AstraZeneca PLC||4,513 GBp||-7.50|
|Medtronic PLC||$76.46 USD||-0.10|
|Novo Nordisk A/S||kr386.00 DKK||+0.30|
|View Industry Companies|